Sen-Jam Pharmaceutical
[Closed for Investment] Sen-Jam Pharmaceutical, with a valuation of $70 million, is raising funds on Dealmaker Securities with a Reg D 506(c) raise. The pharmaceutical company makes highly accessible, safe, and affordable drugs that work. The drugs of Sen-Jam Pharmaceutical combine NSAIDs and antihistamines to prevent inflammation and associated pain. Sen-Jam Pharmaceutical is majorly targeting opioid withdrawal, alcohol hangover prevention, and COVID-19 therapeutic. The company has a strong global IP portfolio with 40 patents and world-class partners. Jim Iversen and Jackie Iversen founded Sen-Jam Pharmaceutical in August 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $10 million. The campaign proceeds will be used to advance the different phases of its clinical trials.
Investment Overview
Deal Terms
- Platform
- Self Managed
- Start Date
- 04/25/2023
- Close Date
- Not Provided
$10,000,000
$10,000,000
$0
Convertible Note
Series A
RegD 506(c)
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Huntington, New York
- Company Website
-
Visit Website
Team
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 03/01/2025 | Wefunder | $80,000,000 | $2,784,326 | Convertible Note | Active | RegCF / RegD 506(c) |
| 01/06/2024 | Self Managed | - | - | Convertible Note | Funded | RegD 506(c) |
| 01/11/2023 | StartEngine | $69,979,019 | $312,093 | Equity - Common | Funded | RegCF |
| 07/31/2022 | Wefunder | $25,000,000 | $1,008,951 | Convertible Note | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.